Anti-CHLE/ BCHE/ BCHED monoclonal antibody

Anti-CHLE/ BCHE/ BCHED antibody for FACS & in-vivo assay

Target products collectionGo to BCHE/BCHE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T99799-Ab-1/ GM-Tg-hg-T99799-Ab-2Anti-Human BCHE monoclonal antibodyHuman
GM-Tg-rg-T99799-Ab-1/ GM-Tg-rg-T99799-Ab-2Anti-Rat BCHE monoclonal antibodyRat
GM-Tg-mg-T99799-Ab-1/ GM-Tg-mg-T99799-Ab-2Anti-Mouse BCHE monoclonal antibodyMouse
GM-Tg-cynog-T99799-Ab-1/ GM-Tg-cynog-T99799-Ab-2Anti-Cynomolgus/ Rhesus macaque BCHE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T99799-Ab-1/ GM-Tg-felg-T99799-Ab-2Anti-Feline BCHE monoclonal antibodyFeline
GM-Tg-cang-T99799-Ab-1/ GM-Tg-cang-T99799-Ab-2Anti-Canine BCHE monoclonal antibodyCanine
GM-Tg-bovg-T99799-Ab-1/ GM-Tg-bovg-T99799-Ab-2Anti-Bovine BCHE monoclonal antibodyBovine
GM-Tg-equg-T99799-Ab-1/ GM-Tg-equg-T99799-Ab-2Anti-Equine BCHE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T99799-Ab-1/ GM-Tg-hg-T99799-Ab-2; GM-Tg-rg-T99799-Ab-1/ GM-Tg-rg-T99799-Ab-2;
GM-Tg-mg-T99799-Ab-1/ GM-Tg-mg-T99799-Ab-2; GM-Tg-cynog-T99799-Ab-1/ GM-Tg-cynog-T99799-Ab-2;
GM-Tg-felg-T99799-Ab-1/ GM-Tg-felg-T99799-Ab-2; GM-Tg-cang-T99799-Ab-1/ GM-Tg-cang-T99799-Ab-2;
GM-Tg-bovg-T99799-Ab-1/ GM-Tg-bovg-T99799-Ab-2; GM-Tg-equg-T99799-Ab-1/ GM-Tg-equg-T99799-Ab-2
Products NameAnti-BCHE monoclonal antibody
Formatmab
Target NameBCHE
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BCHE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CHLE/ BCHE/ BCHED VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm005340mouse Bche Lentivirus plasmid
    ORF Viral VectorvGMLPm005340mouse Bche Lentivirus particle


    Target information

    Target IDGM-T99799
    Target NameBCHE
    Gene ID590,12038,65036,700484,488143,493960,534616,100033901
    Gene Symbol and SynonymsBCHE,BCHED,C730038G20Rik,CHE1,CHE2,E1,EQ-BCHE
    Uniprot AccessionP06276,P32751,P32750,O62760,P32749,P81908
    Uniprot Entry NameCHLE_HUMAN,CHLE_MACMU,CHLE_FELCA,CHLE_CANLF,CHLE_BOVIN,CHLE_HORSE
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseProstate Cancer, Neurological effects, OP toxicity
    Gene EnsemblENSG00000114200
    Target ClassificationN/A

    The target: BCHE, gene name: BCHE, also named as BCHED, CHE1, CHE2, E1. This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.